Unique Populations with Episodic Migraine: Pregnant and Lactating Women
- 250 Downloads
Purpose of Review
Migraine is a disabling and prevalent neurological disease, commonly affecting women during their reproductive years. It is crucial for providers to be able to adequately counsel women who are pregnant, planning pregnancy, or nursing, regarding preventive and abortive treatment options for episodic migraine. This review will discuss (1) the expected course of migraine during pregnancy and the post-partum period, (2) recommended preventive therapies for migraine during pregnancy and lactation, and (3) recommended abortive medications for migraine during pregnancy and lactation.
Recent research has indicated safety for triptan use during pregnancy and ibuprofen use during the first trimester of pregnancy. Considerations for use of emerging migraine-preventive treatment, such as non-invasive neurostimulators, are discussed.
For clinical decision-making and patient counseling, it is important to understand both the limitations in determining teratogenic effects in humans and the principles affecting medication transmission from mother to breast milk.
KeywordsPregnancy Migraine Teratogenicity Lactation Drug safety
Compliance with Ethical Standards
Conflict of Interest
Simy K. Parikh declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 9.• Grossman TB, Robbins MS, Govindappagari S, Dayal AK. Delivery outcomes of patients with acute migraine in pregnancy: a retrospective study. Headache. 2017;57:605–11. Importance: Novel study on pregnancy outcomes for women seeking acute treatment for migraine during pregnancy. Google Scholar
- 16.Glistrap LC, Little BB. In: Gilstrap LC, Little BB, editors. Drugs and pregnancy. 2nd ed. New York: Chapman & Hall; 1998.Google Scholar
- 17.•• Hale T, Rowe HE. Medications and mothers’ milk. 17th ed. Danvers, MA: Springer Publishing Company, LLC; 2017. Importance: Comprehensive resource for assessing lactation risk for medications.Google Scholar
- 25.Ma AG, Schouten EG, Zhang FZ, Kok FJ, Yang F, Jiang DC, et al. Retinol and riboflavin supplementation decreases the prevalence of anemia in Chinese pregnant women taking Iron and folic acid supplements. J Nutr Oxford University Press. 2008;138:1946–50.Google Scholar
- 29.Makrides M, Crosby DD, Bain E, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014.Google Scholar
- 34.Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, et al. Breastfeeding in children of women taking antiepileptic drugs. JAMA Pediatr [Internet]. 2014 [cited 2018 May 19];168:729. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24934501
- 36.Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014;6:CD002252.Google Scholar
- 37.Lusskin SI, Khan SJ, Ernst C, Habib S, Fersh ME, Albertini ES. Pharmacotherapy for perinatal depression. Clin Obstet Gynecol [Internet]. 2018;00:1. Available from: https://doi.org/10.1097/GRF.0000000000000365
- 43.• Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535. Importance: Further reading on transcranial magnetic stimulation for migraine acute treatment. Google Scholar
- 44.• Judkins A, Johnson RL, Murray ST, Yellon SM, Wilson CG. Vagus nerve stimulation in pregnant rats and effects on inflammatory markers in the brainstem of neonates. Pediatr Res. 2018;83:514–9. Importance: Further reading on vagus nerve stimulation for migraine treatment during pregnancy. CrossRefGoogle Scholar
- 46.Namenda XR (memantine hydrochloride) capsules label. [cited 2018 Jul 23]; Available from: www.fda.gov/medwatch.
- 47.•• Dathe K, Fietz A-K, Pritchard LW, Padberg S, Hultzsch S, Meixner K, et al. No evidence of adverse pregnancy outcome after exposure to ibuprofen in the 1st trimester—evaluation of the national embryotox cohort. Reprod Toxicol. 2018;79:32–8. Importance: Recent study evaluating the teratogenicity of ibuprofen use during the first trimester. CrossRefGoogle Scholar
- 49.Childress KS, Dothager C, Gavard J, Lebovitz S, Mostello D. Metoclopramide and diphenhydramine: a randomized controlled trial of a treatment for headache in pregnancy when acetaminophen alone is ineffective (MAD headache study). Am J Obstet Gynecol [Internet]. 2014;210:S277. https://doi.org/10.1016/j.ajog.2013.10.597.CrossRefGoogle Scholar